Ituran Location and Control Ltd.

Shares of Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients. Mesoblast shares jumped 13.4% to $2.4399 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Kidpik Corp. (NASDAQ: PIK) gained 238% to $9.15. Kidpik recently announced a 1-for 5 reverse stock split. TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares surged 149% to $2.6450. TRxADE HEALTH, Inc. (NASDAQ: MEDS) gained 114.6% to $17.26. TRxADE Health recently announced a special cash dividend of $8 per share. Fangdd Network Group Ltd. (NASDAQ: DUO) shares climbed 108% to $1.2593 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services sector. GDS Holdings Limited (NASDAQ: GDS) shares gained 23.7% to $7.93 following a report suggesting Hillhouse and Boyu are in talks to invest in the company's Southeast Asia data center business. Solidion Technology Inc. (NASDAQ: STI) rose 23.3% to $0.9620. Kingsoft Cloud Holdings Limited (NASDAQ: KC) shares gained 23.1% to $3.31. Kingsoft Cloud is expected to report fourth-quarter financial results on March 20, 2024. EHang Holdings Limited (NASDAQ: EH) gained 21.7% to $13.89. EHang Holdings is expected to release its unaudited financial results for the fourth quarter on March 15, 2024. Bally's Corporation (NYSE: BALY) gained 21.5% to $12.90. Standard General delivered a non-binding letter to the board of directors of Bally's proposing a transaction under which it would acquire all of the outstanding shares of common stock for $15/share, not currently owned by the company. Rail Vision Ltd. (NASDAQ: RVSN) climbed 21.2% to $3.43. Rail Vision ...

Related tickers: NBTX, PSTX, VTYX, MEDS, MRAI, PBM, GRPH, PIK, ELTK, EH, TCBP, ITRN, RGF, LYT, LXRX, BNED, SMR, MNKD, MESO, BIAF, MSTR, GDS, PLSE, JFBR, RVSN, ATXI, NWTN, SMCI, IMRN, EGOX, STAA, BILI, CERO, STI, MRNA, SELX, ML, DUO, VNET, LXEH, GNE, BALY, KC.

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results. The company posted a quarterly net loss of $10.1 million, inclusive of $3.2 million in non-cash items, or 12 cents per share for the fourth quarter, versus a year-ago net loss of $14.3 million, inclusive of $6.0 million in non-cash items, or 18 cents per share for the year-ago period. Anavex Life Sciences shares fell 10% to $6.35 on Monday. Here are some other stocks moving in today's mid-day session. Gainers RedHill Biopharma Ltd. (NASDAQ: RDHL) shares climbed 125% to $0.7063 after the company announced the FDA has granted five years' market exclusivity for Talicia. Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) gained 122.8% to $5.96 after the company announced it entered into agreements to acquire an exclusive worldwide license to tolimidone. Tharimmune, Inc. (NASDAQ: THAR) shares climbed 48.6% to $4.28 after the company reported Phase 1 data on TH104 for chronic pruritis in primary biliary cholangitis. Asset Entities Inc. (NASDAQ: ASST) gained 34% to $0.4703 after the company announced a stock repurchase program. Captivision Inc. (NASDAQ: CAPT) rose 20.1% to $2.81 after surging 44% on Friday. Perfect Corp. (NYSE: PERF) climbed 19.7% to $2.9944. The company on Monday announced ...

Related tickers: PGY, OXBR, BDRX, RILY, APLM, INOD, ASST, MIRA, ITRN, THAR, SHOT, PERF, SNES, CAPT, FSR, HUYA, IRS, RELI, PII, PUYI, CHWY, TEO, BGLC, AVXL, AFRM, CLIR, HCWB, TMC, SBET, RDHL, VCXA, AAOI, IOBT, XENE, TCBP, EH.